Business News • PR NewsWire • Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss

Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss

Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss

SHEFFIELD, England, May 20, 2019 /PRNewswire/ -- Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1.4 million in seed funding. The financing, which was co-led by Boehringer Ingelheim Venture ...

View More : https://www.prnewswire.com:443/news-releases/rinri-therapeutics-secures-1-4-million-seed-funding-to-advance-its-novel-re...

Releted News by prnewswire

INVISIO Solution is Selected by USSOCOM for Next Generation Communications System

AR optical waveguide manufacturer Lingxi AR raised A+ round led by Sunny V Fund

Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen

Sasol Limited: Update on the Lake Charles Chemicals Project ('LCCP')

Daimler in transition: focus on sustainability, efficiency and mobility of the future